Skip to search.
 FTSE 100 Up 0.77%

More On SAN.PA

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Sanofi (SAN.PA)

-Paris Ticker: 012057/ISIN: FR0000120578
96.88 Up 0.78(0.81%) 28 Jul 16:35
Add to Portfolio
Prev Close:96.88
Open:96.33
Bid:96.88
Ask:96.91
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:96.21 - 97.50
52wk Range:69.58 - 97.50
Volume:2,297,688
Avg Vol (3m):N/A
Market Cap:127.01b
P/E (ttm):29.71
EPS (ttm):3.26
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback